Teddi Mellencamp sought weight-loss meds amid stage 4 cancer battle

Yorùbá

Teddi Mellencamp, the Real Housewives of Beverly Hills alum, spilled on her podcast that she begged her doctor for GLP-1 weight-loss drugs while battling cancer. She gained weight from steroids but got shut down. Joking about the irony, she quipped about living her best life without the meds.

Hold the phone—Teddi Mellencamp just served some real talk on her 'Two Ts In A Pod' podcast. 😲 The reality star admitted she asked her doc for GLP-1s after steroids packed on the pounds during her Stage 4 melanoma fight. But nope, doctor said no dice, leaving her hilariously frustrated: 'You tell me to live my best life ... but where are my GLP-1s?' 👀

Awọn iroyin ti o ni ibatan

Realistic illustration contrasting social stigma: neutral for overweight, positive for exercise weight loss, negative for Ozempic users.
Àwòrán tí AI ṣe

Study finds people who use Ozempic-like drugs for weight loss face added stigma

Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo

People who lose weight using GLP-1 medications such as Ozempic and Wegovy may be judged more negatively than those who lose weight through diet and exercise — and even more negatively than people who do not lose weight at all — according to a new study led by Rice University psychologist Erin Standen.

Study links GLP-1 drugs to lower breast cancer risk

Women taking GLP-1 medications such as Ozempic and Wegovy showed about 30 percent lower odds of developing breast cancer in a large observational study.

Trojan horse obesity drug boosts weight loss in mice

Ti AI ṣe iroyin

Scientists have developed a hybrid obesity treatment that uses GLP-1 and GIP signals to deliver a metabolic enhancer directly into cells. Early tests in mice showed greater weight loss and better blood sugar control than standard therapies. The approach aims to reduce side effects by limiting the drug's action to targeted areas.

Gossip

Mindy Kaling opens up on weight loss and singledom

Entertainment

Dolly Martinez of 'My 600-Lb. Life' dies at 30

Ìlera

Claims-data study finds many people with type 2 diabetes restart GLP-1 drugs after stopping

Brandi Glanville defends Lisa Vanderpump against Scheana Shay's memoir

Brandi Glanville jumped to Lisa Vanderpump's defense on the latest episode of her podcast. She called out Scheana Shay for writing 'horrible things' about Vanderpump in her memoir. Glanville highlighted Vanderpump's past kindness toward Shay.

Study links Ozempic to lower depression and anxiety risks

Ti AI ṣe iroyin

A large study tracking nearly 100,000 people in Sweden found that GLP-1 receptor agonists like semaglutide, sold as Ozempic and Wegovy, are associated with significantly fewer psychiatric hospital visits and reduced sick days due to mental health issues. Researchers observed drops of up to 47% in various mental health risks during drug use periods. The findings appear in The Lancet Psychiatry.

June 15, 2026 07:24

Oral GLP-1 pill shows strong results in diabetes trial

June 09, 2026 08:37

Katie Thurston shares positive liver cancer update

June 04, 2026 02:30

Kelly Dodd admits secret COVID vaccine and regrets it

June 02, 2026 12:35

Bethenny Frankel claps back at Sports Illustrated runway critics

May 08, 2026 01:19

Japanese study links GLP-1 response to ‘external eating’ habits in people with type 2 diabetes

April 25, 2026 05:27

Young Indians risk health with Ozempic, Mounjaro for pre-wedding weight loss

March 20, 2026 17:08

Cleveland Clinic study finds limited weight regain after stopping GLP-1 drugs

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ